Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
+40,873
New +$1.85M ﹤0.01% 1725
2024
Q2
– Sell
-13,080
Closed -$807K – 2817
2024
Q1
$807K Buy
+13,080
New +$754K 0.01% 990
2023
Q4
– Sell
-80,242
Closed -$2.8M – 2848
2023
Q3
$2.8M Buy
80,242
+48,723
+155% +$1.53M 0.03% 477
2023
Q2
$884K Buy
+31,519
New +$837K 0.01% 1021
2022
Q4
– Sell
-67,273
Closed -$1.4M – 2921
2022
Q3
$1.4M Buy
+67,273
New +$1.23M 0.02% 749
2022
Q2
– Sell
-18,040
Closed -$376K – 3466
2022
Q1
$483K Buy
+18,040
New +$483K ﹤0.01% 1862
2021
Q2
– Sell
-21,766
Closed -$578K – 3308
2021
Q1
$578K Sell
21,766
-250,752
-92% -$7.63M 0.01% 1658
2020
Q4
$8.69M Buy
+272,518
New +$7.39M 0.18% 94

Other funds holding NTNX

HRT Financial's NTNX Position: Q2 2026 in Review

HRT Financial opened a new position in Nutanix (NTNX) in Q2 2026: 40,873 shares worth $2.08M. The stake represents ﹤0.01% of the portfolio and ranks #1725 among its holdings. This is a return to the name: HRT Financial previously reported a position in NTNX as recently as Q1 2024.

HRT Financial first reported a position in NTNX in Q4 2020 and has held it in 8 quarters since. The position peaked at $8.69M in Q4 2020. 564 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

  • HRT Financial held 40,873 shares of Nutanix worth $2.08M as of Q2 2026.
  • Nutanix was a new HRT Financial position in Q2 2026.
  • Nutanix made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1725 holding.
  • HRT Financial first reported a position in Nutanix in Q4 2020 and has held it in 8 quarters since.
  • HRT Financial's Nutanix position peaked at $8.69M in Q4 2020.
  • 564 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.